{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:35:06Z","timestamp":1787063706018,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.056","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T07:30:39Z","timestamp":1629876639000},"page":"5484-5489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine"],"prefix":"10.1016","volume":"39","author":[{"given":"Bruno J.","family":"Lewin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jau","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Y.","family":"Tartof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.056_b0005","unstructured":"Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. In: Hamborsky J, Kroger A, Wolfe S, editors. 13th ed. Washington D.C.: Public Health Foundation; 2015."},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.056_b0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/hep.21439","article-title":"Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes","volume":"44","author":"Taylor","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.15585\/mmwr.su6501a6","article-title":"Progress toward eliminating hepatitis A disease in the United States","volume":"65","author":"Murphy","year":"2016","journal-title":"MMWR Suppl"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/CMR.19.1.63-79.2006","article-title":"Diagnosis of hepatitis a virus infection: a molecular approach","volume":"19","author":"Nainan","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.056_b0025","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S1473-3099(14)70897-7","article-title":"Hepatitis A as a foodborne infection","volume":"14","author":"Wenzel","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.056_b0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12560-018-9349-1","article-title":"Persistence of hepatitis A virus in fresh produce and production environments, and the effect of disinfection procedures: a review","volume":"10","author":"Cook","year":"2018","journal-title":"Food Environ Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.056_b0035","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jam.14727","article-title":"Hepatitis A infections from food","volume":"129","author":"Randazzo","year":"2020","journal-title":"J Appl Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.056_b0040","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.5811\/westjem.2017.10.35983","article-title":"Hepatitis A virus: essential knowledge and a novel identify-isolate-inform tool for frontline healthcare providers","volume":"18","author":"Koenig","year":"2017","journal-title":"West J Emerg Med"},{"issue":"37","key":"10.1016\/j.vaccine.2021.08.056_b0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.15585\/mmwr.mm6637a7","article-title":"Notes from the Field: Increase in Reported Hepatitis A Infections Among Men Who Have Sex with Men - New York City, January-August 2017","volume":"66","author":"Latash","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.08.056_b0050","doi-asserted-by":"crossref","unstructured":"Hosseini M, Ding A. 2189. Hepatitis A Outbreak in San Diego County, 2016\u20132017: A morphologic and epidemiologic review. Open Forum Infect Dis 2018;5(Suppl 1):S646. doi:10.1093\/ofid\/ofy210.1844.","DOI":"10.1093\/ofid\/ofy210.1844"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.056_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.15585\/mmwr.mm6806a6","article-title":"Recommendations of the advisory committee on immunization practices for use of hepatitis A vaccine for persons experiencing homelessness","volume":"68","author":"Doshani","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"43","key":"10.1016\/j.vaccine.2021.08.056_b0060","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.15585\/mmwr.mm6743a3","article-title":"Hepatitis A virus outbreaks associated with drug use and homelessness - California, Kentucky, Michigan, and Utah, 2017","volume":"67","author":"Foster","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"18","key":"10.1016\/j.vaccine.2021.08.056_b0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","article-title":"Increase in Hepatitis A Virus Infections \u2014 United States, 2013\u20132018","volume":"68","author":"Foster","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.08.056_b0070","unstructured":"Current vaccines shortages and delays. Centers for Disease Prevention and Control. https:\/\/www.cdc.gov\/vaccines\/hcp\/clinical-resources\/shortages.html#note1 [accessed 11\/18\/20]."},{"key":"10.1016\/j.vaccine.2021.08.056_b0075","doi-asserted-by":"crossref","unstructured":"Jiang AA, Greenwald HS, Sheikh L, et al. Predictors of acute liver failure in patients with acute hepatitis A: an analysis of the 2016-2018 San Diego County Hepatitis A Outbreak. Open Forum Infect Dis 2019;6(11):ofz467. Published 2019 Nov 5. doi:10.1093\/ofid\/ofz467.","DOI":"10.1093\/ofid\/ofz467"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.056_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10096-020-04028-x","article-title":"Recent outbreaks of severe hepatitis A virus infections in Vienna","volume":"40","author":"Bauer","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2021.08.056_b0085","doi-asserted-by":"crossref","unstructured":"Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020;69(No. RR-5):1\u201338. doi: 10.15585\/mmwr.rr6905a1.","DOI":"10.15585\/mmwr.rr6905a1"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6501a1","article-title":"Surveillance of vaccination coverage among adult populations\u2014United States, 2014","volume":"65","author":"Williams","year":"2016","journal-title":"MMWR Surveill Summ"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.056_b0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","article-title":"Epidemiology and prevention of hepatitis A in travelers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.056_b0100","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jtm.12186","article-title":"Patient awareness of need for hepatitis a vaccination (prophylaxis) before international travel","volume":"22","author":"Liu","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2021.08.056_b0105","doi-asserted-by":"crossref","unstructured":"Yin S, Barker L, Ly KN, et al. Susceptibility to Hepatitis A Virus Infection in the United States, 2007-2016. Clin Infect Dis 2020;71(10):e571\u20139.doi: 10.1093.cid\/ciaa298.","DOI":"10.1093\/cid\/ciaa298"},{"issue":"46","key":"10.1016\/j.vaccine.2021.08.056_b0110","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1016\/j.vaccine.2015.10.009","article-title":"Decreasing immunity to hepatitis A virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999\u20132012","volume":"33","author":"Klevens","year":"2015","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2021.08.056_b0115","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.056_b0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/infdis\/jiu834","article-title":"Trends in disease and complications of hepatitis A virus infection in the United States, 1999\u20132011: a new concern for adults","volume":"212","author":"Ly","year":"2015","journal-title":"J Infect Dis"},{"issue":"S1","key":"10.1016\/j.vaccine.2021.08.056_b0125","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1002\/hep.21052","article-title":"Hepatitis A virus: from discovery to vaccines","volume":"43","author":"Martin","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 10A","key":"10.1016\/j.vaccine.2021.08.056_b0130","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1016\/j.amjmed.2005.07.014","article-title":"Screening for hepatitis A and B antibodies in patients with chronic liver disease","volume":"118","author":"Lau","year":"2005","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.056_b0135","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1708-8305.2006.00043.x","article-title":"Immunity to hepatitis A and hepatitis B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States","volume":"13","author":"Ooi","year":"2006","journal-title":"J Travel Med"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.056_b0140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jiph.2016.09.020","article-title":"Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa","volume":"10","author":"Koroglu","year":"2017","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2310\/7060.2003.30663","article-title":"Immunity to hepatitis A in people born and raised in endemic areas","volume":"10","author":"Barnett","year":"2003","journal-title":"J Travel Med"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1708-8305.1996.tb00692.x","article-title":"Prevalence of hepatitis A antibody in travelers from Hawaii","volume":"3","author":"Ansdell","year":"1996","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.056_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1708-8305.2009.00307.x","article-title":"Hepatitis A risk in travelers","volume":"16","author":"Askling","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2021.08.056_b0160","doi-asserted-by":"crossref","unstructured":"Hepatitis A Vaccine Recommendations. Committee on Infectious Diseases. Pediatrics 2007;120(1):189\u2013199. doi: 10.1542\/peds.2007-1088.","DOI":"10.1542\/peds.2007-1088"},{"key":"10.1016\/j.vaccine.2021.08.056_b0165","unstructured":"U.S. Census Bureau (2018). Demographic and Housing Estimates. American Community Survey 5-Year Estimates. Retrieved 11\/18\/20 from https:\/\/data.census.gov\/cedsci\/table?g=0400000US06&d=ACS%205-Year%20Estimates%20Data%20Profiles&tid=ACSDP5Y2018.DP05."},{"key":"10.1016\/j.vaccine.2021.08.056_b0170","unstructured":"Who and when to test for infection or immunity. US Department of Veterans Affairs. https:\/\/www.hepatitis.va.gov\/hav\/who-to-test.asp [accessed 8\/7\/21]."},{"key":"10.1016\/j.vaccine.2021.08.056_b0175","first-page":"1","article-title":"Viral hepatitis among non-hispanic asian adults in the United States, 2011\u20132014","volume":"225","author":"Kruszon-Moran","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.056_b0180","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1572-0241.2000.01689.x","article-title":"Cost-effective analysis of hepatitis A prevention in Ireland","volume":"95","author":"Rajan","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2021.08.056_b0185","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2004.03.048","article-title":"Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain","volume":"22","author":"Plans-Rubi\u00f3","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.056_b0190","unstructured":"U.S. Census Bureau (2018). Selected Social Characteristics in the United States. American Community Survey 5-Year Estimates. Retrieved 11\/18\/20 from https:\/\/data.census.gov\/cedsci\/table?g=0400000US06&y=2018&d=ACS%205-Year%20Estimates%20Data%20Profiles&tid=ACSDP5Y2018.DP02."},{"issue":"RR-7","key":"10.1016\/j.vaccine.2021.08.056_b0195","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.056_b0200","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.vaccine.2018.01.090","article-title":"Hepatitis A vaccination coverage among adolescents (13\u201317 years) in the United States, 2008\u20132016","volume":"36","author":"Nelson","year":"2018","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.056_b0205","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1111\/trf.14916","article-title":"Distribution of hepatitis A antibodies in US blood donors","volume":"58","author":"Tejada-Strop","year":"2018","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.056_b0210","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00705-017-3294-4","article-title":"Detection and characterization of hepatitis A virus circulating in Egypt","volume":"162","author":"Hamza","year":"2017","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.056_b0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3201\/eid2602.190652","article-title":"Hepatitis A virus genotype IB outbreak among internally displaced persons, Syria","volume":"26","author":"Kaddoura","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.056_b0220","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(14)70883-7","article-title":"Outbreak of hepatitis A in the USA associated with frozen pomegranate arils imported from Turkey: an epidemiological case study","volume":"14","author":"Collier","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.056_b0225","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1111\/j.1365-2893.2010.01410.x","article-title":"What factors determine the severity of hepatitis A-related acute liver failure?","volume":"18","author":"Ajmera","year":"2011","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.056_b0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1708-8305.2009.00320.x","article-title":"Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation","volume":"16","author":"Costas","year":"2009","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2021.08.056_b0235","series-title":"The global prevalence of hepatitis A virus infection and susceptibility: a systematic review","author":"Jacobsen","year":"2009"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.056_b0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2310\/7060.2002.21957","article-title":"Empiric immunization versus serologic screening: developing a cost-effective strategy for the use of hepatitis A immunization in travelers","volume":"9","author":"Fishbain","year":"2002","journal-title":"J Travel Med"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.056_b0245","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/milmed\/167.11.907","article-title":"The utility of prescreening for hepatitis A in military recruits prior to vaccination","volume":"167","author":"Hirota","year":"2002","journal-title":"Mil Med"},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.056_b0250","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.7205\/MILMED-D-12-00355","article-title":"Cost-minimization analysis of the U.S. Army accession screening and immunization program","volume":"177","author":"Tzeng","year":"2012","journal-title":"Mil Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101104X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2101104X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:03:29Z","timestamp":1759403009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2101104X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X2101104X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.056","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}